Archives

by in
Entry Author Date Location
Who Needs VCs? Steven Quay’s Atossa Genetics Seeks Fast IPO For Breast Cancer Test 05/21/10 Seattle
Aragon Pharmaceuticals Moves to First Clinical Trial with $22M 04/22/10 San Diego
Foundation Medicine Raises $25M to Get to the Bottom of Cancer Genomes 04/14/10 Boston
West Wireless Names CEO, Amylin Pharmaceuticals Awaits FDA Deadline, Life Technologies In Cancer Research Partnership, & More San Diego Life Sciences News 03/11/10 San Diego
Life Tech to Sequence Breast Cancer Genomes 03/05/10 San Diego
Roche Prepares to Make Devices for Drug Using Halozyme Therapeutics Technology 01/21/10 San Diego
Calixa Gets Acquired, Pfēnex signs Merck to Licensing Deal, Local Biotechs Report From Breast Cancer Symposium, & More San Diego Life Sciences News 12/17/09 San Diego
San Diego’s BioTheranostics Gears Up to Sell Test That Predicts Breast Cancer Relapse 12/12/09 San Diego
Breast Cancer “Smart Bomb” From Roche, ImmunoGen Shows Tumor Shrinkage in Big Test 12/09/09 Boston
Supercharged Herceptin Nears Pivot Point, as ImmunoGen, Roche Await Data on Breast Cancer “Smart Bomb” 12/07/09 Boston
Acceleron, Bucking Conventional Wisdom, Pushes Ahead Drug For Bone Loss, Anemia 09/11/09 Boston
Amgen’s Dmab Works in Cancer Trial 07/07/09 Seattle
Cell Therapeutics Ships App to FDA, Targeted Genetics Cuts Again, Sanofi CEO Looks to Biotech & More Seattle Area Life Sciences News 06/25/09 Seattle
Breast Cancer Bombshell: Vulcan-Backed BiPar Wows Scientists, Helps Women Live Longer 05/31/09 Seattle
Aragon Pharma Raises $8M 05/21/09 San Diego
Amgen Shows Off Cancer Drug Pipeline Before Scientific Meeting 04/16/09 National
Life Sciences on a Budget: Startups Make Pitch for Angel Dollars at First Zino Society Forum 02/25/09 Seattle
Synta, Developer of New Class of Cancer Drugs, Eagerly Awaits Results From Key Trial 01/27/09 Boston
Amgen Seeks FDA Nod For Bone Drug 12/19/08 Seattle
Ariad Begins Clinical Trial of Breast Cancer Drug 07/30/08 Boston
Page 3 of 3 « previous page